Patient & Visitor InformationContact Us
  • STENTYS (Apposition Trial)

  • Principal Investigator: Paul Gordon, MD

    The purpose of this research study is to evaluate the safety and effectiveness of the STENTYS Coronary Stent in the treatment of narrowed coronary arteries in subjects who are having a heart attack and need to have a coronary angioplasty. Because the STENTYS stent expands on its own without the use of a balloon, it is thought that the STENTYS stent may improve its contact with the heart vessel wall. The STENTYS stent is still in the testing stage and not yet approved for use in the United States.

    The stent will be compared to the currently FDA-approved Multi-Link stent system . The STENTYS stent and the Multi-Link stent are bare metal stents, which means that they do not contain drugs. Bare metal stents have been used for many years and may be an effective treatment for the subject’s condition. Participation in the study is for a total of 3 years. The study follow-ups will be at 1 month, 6 months, 9 months, 1 year, 2 years and 3 years.

    Contact Information:
    Cardiology Research
    The Miriam Hospital  
    164 Summit Ave.  
    Providence, RI 02906
    Lori-Ann Desimore, RN
    401-793-4105